Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Special issue on Ethnobotany

Vol. 11 No. sp1 (2024)

POTENTIAL OF NATURAL BIOACTIVE COMPOUNDS IN MANAGEMENT OF MELASMA

DOI
https://doi.org/10.14719/pst.3164
Submitted
4 December 2023
Published
09-03-2024 — Updated on 01-04-2024
Versions

Abstract

Melasma is a form of inherited hyper-melanosis that appears as asymmetrical, brown-colored, uneven, reticulated macules on UVR-exposed skin, particularly on the facial area. The etiopathogenesis of melasma has been linked to several causes, including UV exposure, endocrine factors, genetic predisposition, anti-epileptic medications, and various cosmetics. The initial course of treatment for hyperpigmentation involves applying topical formulations of widely used substances like kojic acid, glycolic acid, and hydroquinone. Pharmaceuticals such as melatonin, tranexamic acid, and cysteamine hydrochloride are administered orally in this process. Chemical peels and laser therapy are examples of second-line therapies that are applied under the direction of trained experts. Unfortunately, these treatments have certain drawbacks and complications, including erythema, dryness, and skin peeling, and they take time to work, necessitating the use of herbal formulations for the management of hyperpigmentation. Bioactive compounds isolated from plants, such as arbutin, aloesin, flavonoids, hesperidin, licorice, ellagic acids, genistein, and quercetin, inhibit melanogenesis without melanocytotoxicity by different mechanisms. This review provides information on natural bioactive compounds used for the management of melasma.

References

  1. Nautiyal A, Wairkar S. Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell and Melanoma Research. 2021;34(6):1000-14. https://doi.org/10.1111/pcmr.12986.
  2. Mukherjee PK, Biswas R, Sharma A, Banerjee S, Biswas S, Katiyar CK. Validation of medicinal herbs for anti-tyrosinase potential. Journal of herbal medicine. 2018;14:1-6. https://doi.org/10.1016/j.hermed.2018.09.002.
  3. Rathee P, Kumar S, Kumar D, Kumari B, Yadav SS. Skin hyperpigmentation and its treatment with herbs: an alternative method. Future Journal of Pharmaceutical Sciences. 2021; 7:1-4. https://doi.org/10.1186/s43094-021-00284-6.
  4. Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol®. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2002;16(6):567-71. https://doi.org/10.1002/ptr.1085.
  5. Bandyopadhyay D. Topical treatment of melasma. Indian journal of dermatology. 2009 Oct;54(4):303. https://doi.org/10.4103/0019-5154.57602
  6. Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. Anaisbrasileiros de dermatologia. 2014;89:771-82. https://doi.org/10.1590/abd1806-4841.20143063
  7. Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. Journal of cosmetic dermatology. 2007;6(3):195-202. https://doi.org/10.1111/j.1473-2165.2007.00321.x
  8. Kwon SH, Na JI, Choi JY, Park KC. Melasma: Updates and perspectives. Experimental dermatology. 2019;28(6):704-8. https://doi.org/10.1111/exd.13844
  9. Dubey D, Chaudhari L, Biharee A, Verma A, Kumar P, Shrivastava M. An overview of important natural products and phytomedicines used for management of melasma. World Journal of Pharmaceutical Research 2021;10(4): 744-55. https://doi.org/10.20959/wjpr20214-20123
  10. Kang HY, Ortonne JP. Melasma update. ActasDermo-Sifiliográficas. 2009;100:110-3. https://doi.org/10.1016/S0001-7310(09)73385-X
  11. Bagherani N, Gianfaldoni S, Smoller B. An overview on melasma. Pigmentary disorders. 2015;2(10):218. https://doi.org/10.4172/2376-0427.1000216
  12. Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutical approaches in melasma. Dermatologic clinics. 2007;25(3):337-42. https://doi.org/10.1016/j.det.2007.04.006
  13. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. Journal of the American Academy of Dermatology. 2006;55(6):1048-65. https://doi.org/ 10.1016/j.jaad.2006.02.009
  14. Sytar O, Smetanska I. Special issue “Bioactive compounds from natural sources (2020, 2021)”. Molecules. 2022;27(6):1929. https://doi.org/10.3390/molecules27061929
  15. Vashi NA, Kundu RV. Facial hyperpigmentation: causes and treatment. British Journal of Dermatology. 2013;169(s3):41-56. https://doi.org/10.1111/bjd.12536
  16. Jimbow K, Minamitsuji Y. Topical therapies for melasma and disorders of hyperpigmentation. Dermatologic therapy. 2001 ;14(1):35-45. https://doi.org/10.1046/j.1529-8019.2001.014001035.x
  17. Prota G. Melanins and melanogenesis. Academic Press; 2012 Dec 2.
  18. Hatem S, El Hoffy NM, Elezaby RS, Nasr M, Kamel AO, Elkheshen SA. Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches. Journal of drug delivery science and technology. 2020;60:101984. https://doi.org/10.1016/j.jddst.2020.101984
  19. D'Angelo Costa GM, Maia Campos PM. Efficacy of topical antioxidants in the skin hyperpigmentation control: A clinical study by reflectance confocal microscopy. Journal of Cosmetic Dermatology. 2021;20(2):538-45. https://doi.org/10.1111/jocd.13804
  20. Daroach M, Vinay K, Bishnoi A, Parsad D, Kumaran MS. Extrafacial Melasma: A Scenario Less Explored. Indian Dermatology Online Journal. 2022;13(4):484. https://doi.org/10.4103/idoj.idoj_463_21
  21. Kauh YC, Zachian TF. Melasma. RheumaDerm: current issues in rheumatology and dermatology. 1999:491-9. https://doi.org/10.1007/978-1-4615-4857-7_72
  22. Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K. Tranexamic acid in melasma: A focused review on drug administration routes. Journal of Cosmetic Dermatology. 2023. https://doi.org/ 10.1111/jocd.15589
  23. Victor FC, Gelber J, Rao B. Melasma: a review. Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology. 2004;8:97-102. https://doi.org/10.1007/s10227-004-0158-9
  24. Dessinioti C. Clio Dessinioti, Torello M. Lotti, Alexander J. Stratigos, KaterinaDamevska, and Andreas D. Katsambas. European Handbook of Dermatological Treatments.:613.
  25. Lee AY. Recent progress in melasma pathogenesis. Pigment cell & melanoma research. 2015;28(6):648-60. https://doi.org/10.1111/pcmr.12404
  26. Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatology and therapy. 2017:7:305-18. https://doi.org/10.1007/s13555-017-0194-1
  27. Duteil L, Cadars B, Queille?Roussel C, Giraud I, Drulhon F, Graizeau C, Guyoux A, Passeron T. A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light. Journal of the European Academy of Dermatology and Venereology. 2022;36(6):922-6. https://doi.org/ 10.1111/jdv.18034
  28. Handbook of dermatological treatments. Vol. 613.
  29. Arefiev KL, Hantash BM. Advances in the treatment of melasma: a review of the recent literature. Dermatologic surgery. 2012 ;38(7 pt1):971-84.https://doi.org/10.1111/j.1524-4725.2012.02435.x
  30. Espinal?Perez LE, Moncada B, Castanedo?Cazares JP. A double?blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. International journal of dermatology. 2004;43(8):604-7. https://doi.org/10.1111/j.1365-4632.2004.02134.x
  31. Chatterjee M, Vasudevan B. Recent advances in melasma. Pigment International. 2014 Jul 1;1(2):70-80. https://doi.org/10.4103/2349-5847.147044
  32. Vachiramon V, Suchonwanit P, Thadanipon K. Melasma in men. Journal of Cosmetic Dermatology. 2012;11(2):151-7. https://doi.org/10.1111/j.1473-2165.2012.00613.
  33. Damevska K. New aspects of melasma/novi aspekti melazme. Serbian Journal of Dermatology and Venereology. 2014;6(1):5-18.https://doi.org/10.2478/sjdv-2014-0001.
  34. Cestari T, Arellano I, Hexsel D, Ortonne JP, Latin American Pigmentary Disorders Academy. Melasma in Latin America: options for therapy and treatment algorithm. Journal of the European Academy of Dermatology and Venereology. 2009;23(7):760-72. https://doi.org/10.1111/j.1468-3083.2009.03251.x
  35. Grimes PE, Ijaz S, Nashawati R, Kwak D. New oral and topical approaches for the treatment of melasma. International Journal of Women's Dermatology. 2019;5(1):30-6. https://doi.org/ 10.1016/j.ijwd.2018.09.004
  36. Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. American journal of clinical dermatology. 2013;14:359-76. https://doi.org/ 10.1007/s40257-013-0038-4
  37. Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K. Tranexamic acid in melasma: A focused review on drug administration routes. Journal of Cosmetic Dermatology. 2023;22(4):1197-206.https://doi.org/10.1111/jocd.15589
  38. Babbush KM, Babbush RA, Khachemoune A. The therapeutic use of antioxidants for melasma. J Drugs Dermatol. 2020;19(8):788-92. https://doi.org/10.36849/JDD.2020.5079
  39. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. Journal of the American Academy of Dermatology. 2006;55(6):1048-65. https://doi.org/10.1016/j.jaad.2006.02.009
  40. Bergler-Czop B, Bilewicz-Stebel M, Sta?kowsk A, Bilewicz-Wyrozumska T. Side effects of retinoid therapy on the quality of vision. Acta Pharmaceutica. 2016;66(4):471-8. https://doi.org/10.1515/acph-2016-0039
  41. Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. Journal of the American Academy of Dermatology. 2006;54(5):S272-81. https://doi.org/10.1016/j.jaad.2005.12.039
  42. Mahajan VK, Patil A, Blicharz L, Kassir M, Konnikov N, Gold MH, Goldman MP, Galadari H, Goldust M. Medical therapies for melasma. Journal of Cosmetic Dermatology. 2022;21(9):3707-28. https://doi.org/10.1111/jocd.15242
  43. Torok HM. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. American Journal of Clinical Dermatology. 2006;7:223-30. https://doi.org/10.2165/00128071-200607040-00003
  44. Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, Menter A, Baumann L, Wieder JJ, Jarratt MM, Pariser D. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis-New York. 2003;72(1):67-73.
  45. Šitum M, Koli? M, Bolan?a Ž, Ljubi?i? I, Mišanovi? B. Melasma–updated treatments. Collegium Antropologicum. 2011;35(2):315-8.
  46. Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. ActaDermato-Venereologica. 2017;97(7):776-81. https://doi.org/ 10.2340/00015555-2668
  47. Wang JV, Jhawar N, Saedi N. Tranexamic acid for melasma: evaluating the various formulations. The Journal of Clinical and Aesthetic Dermatology. 2019;12(8):E73.
  48. Poojary S, Minni K. Tranexamic acid in melasma: A review. Pigment Disord. 2015;2(12):228. https://doi.org/10.4172/2376-0427.1000228
  49. Zhu CY, Li Y, Sun QN, Takada A, Kawada A. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study. European Journal of Dermatology. 2019;29:55-8. https://doi.org/10.1684/ejd.2018.3494
  50. Azzam OA, Leheta TM, Nagui NA, Shaarawy E, Hay RM, Hilal RF. Different therapeutic modalities for treatment of melasma. Journal of Cosmetic Dermatology.2009;8(4):275-81. https://doi.org/10.1111/j.1473-2165.2009.00471.x
  51. Yenny SW. Comparison of the use of 5% methimazole cream with 4% kojic acid in melasma treatment. Turk Dermatoloji Dergisi. 2018;12(4):167. https://doi.org/10.4274/tdd.3640
  52. Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. International journal of women's dermatology. 2017;3(1):11-20. https://doi.org/10.1016/j.ijwd.2017.01.004
  53. Iranmanesh B, Khalili M, Mohammadi S, Amiri R, Aflatoonian M. The efficacy of energy?based devices combination therapy for melasma. Dermatologic therapy. 2021;34(3):e14927. https://doi.org/10.1111/dth.14927
  54. Handog EB, Galang DA, De Leon?Godinez MA, Chan GP. A randomized, double?blind, placebo?controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women. International Journal Of Dermatology. 2009;48(8):896-901. https://doi.org/10.1111/j.1365-4632.2009.04130.x
  55. Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. Journal of Cosmetic Dermatology. 2013;12(1):57-66. https://doi.org/ 10.1111/jocd.12026
  56. Jain P, Taleuzzaman M, Kala C, Kumar Gupta D, Ali A, Aslam M. Quality by design (Qbd) assisted development of phytosomal gel of aloe vera extract for topical delivery. Journal of Liposome Research. 2021;31(4):381-8. https://doi.org/ 10.1080/08982104.2020.1849279,
  57. Yamakoshi J, Sano A, Tokutake S, Saito M, Kikuchi M, Kubota Y, Kawachi Y, Otsuka F. Oral intake of proanthocyanidin?rich extract from grape seeds improves chloasma. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2004;18(11):895-9. https://doi.org/ 10.1002/ptr.1537
  58. Rafique M, Shah SN, Hussain I, Javed I, Nisar N, Riaz R. Development of grape seed extract based formulations by using non-invasive biophysical technique and its impact on skin aging. Pakistan Journal of Pharmaceutical Sciences. 2021;34. https://doi.org/ 10.36721/pjps.2021.34.4.sup.1621-1628.1
  59. Tao K, Guo L, Hu X, Fitzgerald C, Rouzard K, Healy J, Tamura M, Stock JB, Stock M, Pérez E, Fernández JR. Encapsulated Activated Grape Seed Extract: A Novel Formulation with Anti-Aging, Skin-Brightening, and Hydration Properties. Cosmetics. 2021;9(1):4. https://doi.org/ 10.3390/cosmetics9010004
  60. Pinto CA, Delfes MF, Reis LM, Garbers LE, Passos PC, Torre DS. Uso do pycnogenol no tratamento do melasma. Surgical & Cosmetic Dermatology. 2015;7(3):218-22. https://doi.org/ 10.5935/scd 1984-8773.201573663
  61. Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. In Journal of Investigative Dermatology Symposium Proceedings 2008 Apr 1 (Vol. 13, No. 1, pp. 20-24). Elsevier. https://doi.org/ 10.1038/jidsymp.2008.8
  62. Ku B, Kim D, Choi EM. Anti-melanogenic effect of the aqueous ethanol extract of Ginkgo biloba leaf in B16F10 cells. Toxicology and Environmental Health Sciences. 2020;12:287-95. https://doi.org/ 10.1007/s13530-020-00063-5
  63. Mikayoulou M, Mayr F, Temml V, Pandian A, Vermaak I, Chen W, Komane B, Stuppner H, Viljoen A. Anti-tyrosinase activity of South African Aloe species and isolated compounds plicataloside and aloesin. Fitoterapia. 2021;150:104828. https://doi.org/ 10.1016/j.fitote.2021.104828
  64. Ghafarzadeh M, Eatemadi A. Clinical efficacy of liposome-encapsulated Aloe vera on melasma treatment during pregnancy. Journal of cosmetic and laser therapy. 2017;19(3):181-7. https://doi.org/ 10.1080/14764172.2017.1279329
  65. Joshua JM, Anilkumar AT, Cu VE, T Vasudevan DE, Surendran SA. Formulation and evaluation of antiaging phytosomal gel. Asian J Pharm Clin Res. 2018;11(3):409-22. https://doi.org/ 10.22159/ajpcr.2018.v11i3.24257
  66. Korkij W, Bhunratanakornkij L, Wakawakyanon S. Efficacy of Aloe vera leaves extraction the treatment of melasma. Chulalongkorn Medical Journal. 1991;35(8):501-6. https://doi.org/ 10.58837/chula.cmj.35.8.5
  67. Chiang HM, Chen CW, Chen CC, Wang HW, Jhang JH, Huang YH, Wen KC. Role of Coffea arabica extract and related compounds in preventing photoaging and photodamage of the skin. In Coffee in Health and Disease Prevention 2015 (pp. 523-530). Academic Press. https://doi.org/ 10.1016/B978-0-12-409517-5.00058-9
  68. Saewan N. Effect of coffee berry extract on anti-aging for skin and hair—In vitro approach. Cosmetics. 2022;9(3):66. https://doi.org/ 10.3390/cosmetics9030066
  69. Murray MT. Glycyrrhiza glabra (Licorice). Textbook of Natural Medicine. 2020:641.
  70. Amer M, Metwalli M. Topical liquiritin improves melasma. International journal of dermatology. 2000;39(4):299-301. https://doi.org/ 10.1046/j.1365-4362.2000.00943.x
  71. Maddaleno AS, Camargo J, Mitjans M, Vinardell MP. Melanogenesis and melasma treatment. Cosmetics. 2021;8(3):82. https://doi.org/ 10.3390/cosmetics8030082
  72. Sarkar R, Bansal A, Ailawadi P. Future therapies in melasma: What lies ahead?. Indian journal of dermatology, venereology and leprology. 2020;86:8. https://doi.org/ 10.4103/ijdvl.ijdvl_633_18
  73. Halder RM, Nordlund JJ. Topical treatment of pigmentary disorders. The pigmentary system: Physiology and pathophysiology. 2006:1163-74. https://doi.org/ 10.1111/exd.13844
  74. Malik A, Khan MH, Khan SB, Ahmad A, Choudhary MI. Tyrosinase inhibitory lignans from the methanol extract of the roots of Vitex negundo Linn. and their structure–activity relationship. Phytomedicine. 2006 Mar 13;13(4):255-60. https://doi.org/ 10.1016/j.phymed.2004.09.001
  75. Huang HC, Chang TY, Chang LZ, Wang HF, Yih KH, Hsieh WY, Chang TM. Inhibition of melanogenesis versus antioxidant properties of essential oil extracted from leaves of Vitex negundo Linn and chemical composition analysis by GC-MS. Molecules. 2012;17(4):3902-16. https://doi.org/ 10.3390/molecules17043902
  76. GoelzerNeto CF, do Nascimento P, da Silveira VC, de Mattos AB, Bertol CD. Natural sources of melanogenic inhibitors: A systematic review. International Journal of Cosmetic Science. 2022 Apr;44(2):143-53. https://doi.org/ 10.1111/ics.12763
  77. Chang LW, Juang LJ, Wang BS, Wang MY, Tai HM, Hung WJ, Chen YJ, Huang MH. Antioxidant and antityrosinase activity of mulberry (Morus alba L.) twigs and root bark. Food and Chemical Toxicology. 2011;49(4):785-90. https://doi.org/ 10.1016/j.fct.2010.11.045
  78. Yang Z, Wang Y, Wang Y, Zhang Y. Bioassay-guided screening and isolation of ?-glucosidase and tyrosinase inhibitors from leaves of Morusalba. Food chemistry. 2012 Mar 15;131(2):617-25. https://doi.org/ 10.1016/j.foodchem.2011.09.040
  79. Nomakhosi M, Heidi A. Natural options for management of melasma. Journal of Cosmetic and Laser Therapy. 2018;20(7-8):470-81. https://doi.org/ 10.1080/14764172.2018.1427874
  80. Babbush KM, Babbush RA, Khachemoune A. The therapeutic use of antioxidants for melasma. J Drugs Dermatol. 2020;19(8):788-92. https://doi.org/ 10.36849/JDD.2020.5079
  81. Lee HR, Jung JM, Seo JY, Chang SE, Song Y. Anti-melanogenic property of ginsenoside Rf from Panax ginseng via inhibition of CREB/MITF pathway in melanocytes and ex vivo human skin. Journal of Ginseng Research. 2021;45(5):555-64. https://doi.org/ 10.1016/j.jgr.2020.11.003
  82. Liu J, Jiang R, Zhou J, Xu X, Sun Z, Li J, Chen X, Li Z, Yan X, Zhao D, Zheng Z. Salicylic acid in ginseng root alleviates skin hyperpigmentation disorders by inhibiting melanogenesis and melanosome transport. European Journal of Pharmacology. 2021;910:174458. https://doi.org/ 10.1016/j.ejphar.2021.174458
  83. Vaibhav S, Lakshaman K. Tyrosinase enzyme inhibitory activity of selected Indian herbs. Int J Res Pharm Biomed Sci. 2012;3:977-82.
  84. Baby AR, Freire TB, Marques GD, Rijo P, Lima FV, Carvalho JC, Rojas J, Magalhães WV, Velasco MV, Morocho-Jácome AL. Azadirachta indica (Neem) as a potential natural active for dermocosmetic and topical products: a narrative review. Cosmetics. 2022;9(3):58. https://doi.org/ 10.3390/cosmetics9030058
  85. Bahuguna A, Bharadwaj S, Chauhan AK, Kang SC. Inhibitory insights of strawberry (Fragaria× ananassa var. Seolhyang) root extract on tyrosinase activity using computational and in vitro analysis. International Journal of Biological Macromolecules. 2020;165:2773-88. https://doi.org/ 10.1016/j.ijbiomac.2020.10.135, PMID 33470201
  86. Harahap ES, Ginting CN, Lubis YM, Chiuman L. The Activity of Strawberry Extract as Sunscreen on Guinea Pigs Exposed to Sunlight. In IOP Conference Series: Earth and Environmental Science 2022 Sep 1 (Vol. 1083, No. 1, p. 012007). IOP Publishing. https://doi.org/ 10.1088/1755-1315/1083/1/012007
  87. Singhal A, Kumar D, Bansal M. Skin Whitening-A Brief Review. Skin. 2013;1(2):3-4.

Downloads

Download data is not yet available.